Complete Filing Data
Silo Pharma, Inc. reported Stockholders Equity of $6.31 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Silo Pharma, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$4.2M | -$4.4M | -$3.7M | -$3.9M | $3.9M | -$3.0M | -$1.0M | -$969.5K | $356.5K | -$39.4K | -$49.8K | |
| Cost of Revenue * | $44.3K | $5.8K | $5.8K | $5.8K | $5.0K | $176.1K | $27.4K | |||||
| Operating Expenses | $4.3M | $4.8M | $3.9M | $3.7M | $2.8M | $2.2M | $943.6K | $594.2K | $490.9K | |||
| Operating Income Loss | -$4.3M | -$4.7M | -$3.9M | -$3.6M | -$2.7M | -$2.2M | -$930.4K | -$594.2K | -$490.9K | |||
| Nonoperating Income Expense | $53.0K | $312.8K | $224.5K | -$279.7K | $6.9M | -$464.6K | -$82.9K | -$375.2K | $847.4K | |||
| Gross Profit | $27.8K | $66.3K | $66.3K | $66.3K | $66.3K | -$135.2K | $13.2K | |||||
| Research And Development Expense | $2.2M | $2.4M | $845.1K | $1.3M | $693.9K | $26.3K | ||||||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$4.2M | -$4.4M | -$3.6M | -$3.9M | $4.2M | -$2.7M | ||||||
| General And Administrative Expense | $120.8K | $87.0K | $76.1K | $29.6K | $10.3K | $39.4K | $49.8K | |||||
| Revenues | $72.1K | $72.1K | $72.1K | $72.1K | $40.9K | $40.6K | ||||||
| Selling General And Administrative Expense | $390.1K | $227.3K | $163.0K | $50.2K | ||||||||
| Net Income Loss Available To Common Stockholders Diluted | -$3.9M | $2.5M | -$3.1M | -$1.0M | ||||||||
| Income Loss From Continuing Operations | -$4.4M | -$3.6M | -$3.9M | $4.2M | -$2.7M | |||||||
| Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity | -$69.6K | -$1.2K | -$253.4K | -$371.2K | ||||||||
| Comprehensive Income Net Of Tax | -$4.2M | -$4.4M | -$3.7M | -$3.9M | ||||||||
| Discontinued Operation Income Loss From Discontinued Operation Before Income Tax | -$69.6K | -$1.2K | -$254.9K | -$371.2K | ||||||||
| Income Loss From Discontinued Operations Net Of Tax Per Basic Share | -$0.02 | $0.00 | -$0.13 | |||||||||
| Interest Expense Debt | $3.0K | $269.0K | $62.7K | |||||||||
| Income Loss From Discontinued Operations Net Of Tax Per Diluted Share | -$0.02 | $0.00 | -$0.13 | |||||||||
| Interest Expense Nonoperating | $37.3K | $5.1K | $4.9K | |||||||||
| Income Loss From Continuing Operations Per Diluted Share | -$1.19 | -$1.18 | -$1.71 | $1.43 | ||||||||
| Income Loss From Continuing Operations Per Basic Share | -$1.19 | -$1.18 | -$1.71 | $1.45 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q3 2017 | Q3 2013 | Q2 2013 | Q1 2013 | Q3 2012 | Q2 2012 | Q1 2012 | Q3 2011 | Q2 2011 | Q1 2011 | Q3 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$1.1M | -$1.2M | -$1.0M | -$928.8K | -$931.8K | -$801.7K | -$660.2K | -$1.0M | -$906.4K | -$983.2K | -$658.4K | -$604.1K | $6.4M | -$462.0K | -$930.7K | -$633.8K | -$1.4M | -$238.9K | -$265.5K | -$242.2K | -$123.5K | -$198.2K | -$315.9K | $17.5K | -$5.7K | -$22.5K | -$22.9K | -$8.6K | -$5.7K | -$13.0K | -$17.7K | -$13.9K | -$11.9K | -$450.00 | |
| Cost of Revenue * | $20.7K | $1.5K | $1.5K | $1.5K | $1.5K | $1.5K | $1.5K | $1.5K | $1.5K | $1.5K | $1.5K | $1.5K | $1.5K | $1.5K | $625.00 | $29.4K | $1.3K | $84.00 | $82.00 | ||||||||||||||||
| Operating Expenses | $1.1M | $1.3M | $1.1M | $1.0M | $1.0M | $896.1K | $790.0K | $1.1M | $820.1K | $965.7K | $510.9K | $543.8K | $480.5K | $453.4K | $917.7K | $558.9K | $997.6K | $159.6K | $242.7K | $189.9K | $174.6K | $81.2K | $76.1K | $134.9K | $98.2K | ||||||||||
| Operating Income Loss | -$1.2M | -$1.2M | -$1.1M | -$1.0M | -$1.0M | -$879.5K | -$773.4K | -$1.1M | -$803.5K | -$949.2K | -$494.3K | -$527.3K | -$463.9K | -$436.8K | -$901.1K | -$558.9K | -$996.7K | -$159.4K | -$242.5K | -$189.9K | -$174.6K | -$81.2K | -$76.1K | -$134.9K | |||||||||||
| Nonoperating Income Expense | $41.0K | $44.3K | $62.7K | $81.2K | $71.0K | $77.8K | $113.2K | $102.0K | -$102.9K | -$34.1K | -$164.1K | -$75.7K | $7.0M | $48.0K | $37.4K | $2.4K | -$378.3K | -$79.5K | -$23.0K | -$52.3K | $51.0K | -$117.0K | -$239.8K | $152.4K | |||||||||||
| Gross Profit | -$2.7K | $16.6K | $16.6K | $16.6K | $16.6K | $16.6K | $16.6K | $16.6K | $16.6K | $16.6K | $16.6K | $16.6K | $16.6K | $16.6K | $16.6K | -$13.2K | $883.00 | $210.00 | $186.00 | ||||||||||||||||
| Research And Development Expense | $543.6K | $717.2K | $594.0K | $517.5K | $392.8K | $318.2K | $174.5K | $130.7K | $202.9K | $375.8K | $105.7K | $170.3K | $70.5K | $98.8K | $48.6K | ||||||||||||||||||||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$1.1M | -$1.2M | -$1.0M | -$928.8K | -$931.8K | -$801.7K | -$660.2K | -$1.0M | -$906.4K | -$983.2K | -$658.4K | -$602.9K | $6.5M | -$388.8K | -$863.7K | -$556.5K | |||||||||||||||||||
| General And Administrative Expense | $28.4K | $30.7K | $17.0K | $44.6K | $18.8K | $12.3K | $6.4K | $8.8K | $9.9K | $7.3K | $5.7K | $22.5K | $22.9K | $8.6K | $5.7K | $13.0K | $17.7K | $13.9K | $11.9K | $450.00 | |||||||||||||||
| Revenues | $18.0K | $18.0K | $18.0K | $18.0K | $18.0K | $18.0K | $18.0K | $18.0K | $18.0K | $18.0K | $18.0K | $68.1K | $47.4K | $16.3K | $2.2K | $294.00 | $268.00 | ||||||||||||||||||
| Selling General And Administrative Expense | $50.6K | $64.4K | $239.1K | $65.0K | $60.3K | $25.9K | $36.8K | $24.6K | $45.7K | $71.0K | $7.6K | $30.7K | $17.0K | ||||||||||||||||||||||
| Net Income Loss Available To Common Stockholders Diluted | -$983.2K | -$658.4K | -$604.1K | $6.4M | -$462.0K | -$2.3M | -$633.8K | -$1.4M | -$238.9K | -$265.5K | -$242.2K | ||||||||||||||||||||||||
| Income Loss From Continuing Operations | -$660.2K | -$1.0M | -$906.4K | -$983.2K | -$658.4K | -$602.9K | $6.5M | -$388.8K | -$863.7K | -$556.5K | |||||||||||||||||||||||||
| Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity | -$1.2K | -$87.3K | -$73.2K | -$67.0K | -$77.3K | ||||||||||||||||||||||||||||||
| Comprehensive Income Net Of Tax | -$1.1M | -$1.2M | -$1.0M | -$917.0K | -$949.9K | -$769.3K | -$657.6K | -$1.0M | -$901.2K | -$983.2K | -$658.4K | -$604.1K | |||||||||||||||||||||||
| Discontinued Operation Income Loss From Discontinued Operation Before Income Tax | -$1.2K | -$88.9K | -$73.2K | -$67.0K | -$77.3K | ||||||||||||||||||||||||||||||
| Income Loss From Discontinued Operations Net Of Tax Per Basic Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | -$0.04 | ||||||||||||||||||||||||||||
| Interest Expense Debt | $483.00 | $1.0K | $1.3K | $393.00 | $186.1K | $82.5K | $94.00 | $316.00 | |||||||||||||||||||||||||||
| Income Loss From Discontinued Operations Net Of Tax Per Diluted Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | -$0.04 | ||||||||||||||||||||||||||||
| Interest Expense Nonoperating | $886.00 | $1.6K | $2.1K | $1.1K | $1.9K | $1.9K | $1.1K | $1.9K | |||||||||||||||||||||||||||
| Income Loss From Continuing Operations Per Diluted Share | -$0.21 | -$0.32 | -$0.29 | -$0.49 | -$0.33 | -$0.31 | $3.20 | ||||||||||||||||||||||||||||
| Income Loss From Continuing Operations Per Basic Share | -$0.21 | -$0.32 | -$0.29 | -$0.49 | -$0.33 | -$0.31 | $3.24 |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity * | $6.3M | $5.0M | $6.2M | $10.3M | $9.1M | $1.3M | -$22.9K | $407.4K | $1.2M | $846.5K | $1.8M | -$41.2K | -$1.7K | $47.5K |
| Cash And Cash Equivalents At Carrying Value | $4.7M | $3.9M | $3.5M | $11.4M | $9.8M | $1.1M | $336.7K | $294.6K | $579.2K | $2.0M | $279.00 | $1.8K | $47.5K | |
| Liabilities And Stockholders Equity | $7.6M | $7.4M | $7.7M | $11.6M | $10.5M | $1.4M | $493.8K | $855.4K | $1.6M | $2.2M | $279.00 | $1.8K | $47.5K | |
| Common Stock Value | $1.3K | $449.00 | $316.00 | $316.00 | $197.00 | $8.5K | $2.4K | $2.3K | $5.0K | $4.1K | $3.1K | $3.1K | $3.1K | |
| Assets | $7.6M | $7.4M | $7.7M | $11.6M | $10.5M | $1.4M | $493.8K | $855.4K | $1.6M | $2.2M | $279.00 | $1.8K | $47.5K | |
| Assets Current | $7.4M | $7.1M | $7.7M | $11.6M | $10.4M | $1.4M | $493.8K | $626.0K | $1.6M | $1.8K | $47.5K | |||
| Liabilities Current | $650.2K | $1.7M | $775.6K | $436.3K | $490.0K | $141.7K | $116.7K | $48.0K | $38.3K | $3.5K | $0.00 | |||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $4.7M | $3.9M | $3.5M | $11.4M | $9.8M | $1.1M | $111.8K | |||||||
| Accounts Payable And Accrued Liabilities Current | $578.1K | $1.6M | $703.5K | $364.2K | $127.1K | $54.9K | $25.6K | $38.3K | $2.1K | $20.7K | $3.5K | |||
| Retained Earnings Accumulated Deficit | -$19.5M | -$15.3M | -$10.9M | -$7.2M | -$3.3M | -$5.8M | -$2.7M | -$1.6M | ||||||
| Prepaid Expense And Other Assets Current | $208.6K | $31.0K | $16.0K | $135.9K | $145.3K | $241.1K | $16.3K | $34.0K | $26.6K | |||||
| Liabilities | $1.3M | $2.4M | $1.6M | $1.3M | $1.4M | $146.0K | $116.7K | $18.7K | $41.5K | $3.5K | ||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | $842.9K | $381.5K | -$7.8M | $1.5M | $8.7M | $1.0M | -$224.9K | |||||||
| Liabilities Noncurrent | $649.5K | $721.6K | $793.7K | $865.8K | $937.9K | $4.2K | ||||||||
| Unrealized Gain Loss On Investments | -$3.2K | -$3.1K | -$331.2K | $248.6K | -$9.2K | -$170.2K | -$278.7K | $912.1K | $65.1K | |||||
| Unrealized Gain Loss On Equity Investments | -$331.2K | $248.6K | -$9.2K | -$170.2K | -$278.7K | $912.1K | ||||||||
| Bad Debt Recovery Expense | -$148.5K | $165.4K | -$13.5K | $35.0K | ||||||||||
| Cash And Cash Equivalents Period Increase Decrease | -$224.9K | $42.1K | -$284.6K | $2.0M | -$1.5K | -$45.7K | ||||||||
| Short Term Investments | $2.1M | $3.2M | $4.1M | |||||||||||
| Gain Loss On Investments | -$104.7K | $6.7M | $104.9K | |||||||||||
| Assets Noncurrent | $217.4K | $300.4K | $65.0K | $229.4K | ||||||||||
| Treasury Stock Value Acquired Cost Method | $173.1K | $471.1K | $1.0M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q3 2017 | Q3 2013 | Q2 2013 | Q1 2013 | Q4 2012 | Q3 2012 | Q2 2012 | Q1 2012 | Q4 2011 | Q3 2011 | Q2 2011 | Q1 2011 | Q4 2010 | Q3 2010 | Q2 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity * | $5.0M | $4.9M | $4.0M | $6.8M | $6.0M | $5.3M | $7.5M | $8.3M | $9.4M | $11.9M | $7.9M | $8.5M | $10.2M | $3.8M | $4.2M | $1.3M | $2.1M | $2.3M | -$261.5K | -$22.9K | -$101.3K | $102.9K | $292.7K | $1.0M | $904.7K | $1.2M | $996.2K | $543.6K | $333.4K | -$44.1K | -$29.0K | -$20.5K | -$14.8K | -$1.7K | $4.6K | $22.3K | $47.5K | |||||
| Cash And Cash Equivalents At Carrying Value | $3.9M | $4.3M | $3.1M | $4.9M | $4.5M | $2.7M | $199.8K | $158.8K | $4.7M | $12.3M | $8.7M | $9.1M | $10.3M | $4.2M | $4.6M | $1.6M | $1.9M | $9.1K | $111.8K | $24.6K | $77.0K | $177.3K | $626.1K | $776.2K | $486.3K | $301.7K | $1.3M | $368.7K | $10.1K | $279.00 | $813.00 | $3.7K | $8.1K | $25.8K | $36.2K | $8.1K | $0.00 | |||||
| Liabilities And Stockholders Equity | $6.4M | $6.7M | $5.9M | $8.6M | $8.0M | $6.9M | $9.0M | $10.2M | $11.0M | $13.0M | $9.0M | $9.7M | $11.4M | $5.0M | $5.5M | $2.2M | $2.8M | $403.8K | $386.5K | $535.5K | $750.9K | $1.4M | $1.3M | $368.7K | $10.1K | $279.00 | $813.00 | $3.7K | $4.6K | $25.8K | ||||||||||||
| Common Stock Value | $1.0K | $865.00 | $449.00 | $449.00 | $408.00 | $316.00 | $311.00 | $311.00 | $316.00 | $314.00 | $9.9K | $9.9K | $9.9K | $9.9K | $8.5K | $8.5K | $8.3K | $2.4K | $2.3K | $2.3K | $2.3K | $5.2K | $3.6K | $3.1K | $3.1K | $3.1K | $3.1K | $3.1K | $3.1K | $3.1K | ||||||||||||
| Assets | $6.4M | $6.7M | $5.9M | $8.6M | $8.0M | $6.9M | $9.0M | $10.2M | $11.0M | $13.0M | $9.0M | $9.7M | $11.4M | $5.0M | $5.5M | $2.2M | $2.8M | $403.8K | $386.5K | $535.5K | $750.9K | $1.4M | $1.3M | $368.7K | $10.1K | $279.00 | $813.00 | $3.7K | $4.6K | $25.8K | ||||||||||||
| Assets Current | $6.2M | $6.4M | $5.6M | $8.3M | $7.7M | $6.9M | $8.9M | $10.2M | $11.0M | $12.9M | $8.9M | $9.6M | $11.3M | $5.0M | $5.5M | $2.1M | $2.8M | $403.8K | $157.1K | $306.1K | $521.4K | $1.1M | $1.3M | $368.7K | $10.1K | $279.00 | $279.00 | $813.00 | $3.7K | $4.6K | $25.8K | |||||||||||
| Liabilities Current | $708.3K | $1.0M | $1.2M | $1.0M | $1.3M | $873.7K | $678.8K | $1.1M | $732.4K | $312.2K | $268.8K | $292.7K | $283.4K | $264.1K | $327.0K | $122.0K | $80.1K | $265.6K | $87.8K | $32.6K | $58.2K | $28.7K | $715.5K | $35.2K | $54.2K | $25.7K | $14.3K | $6.3K | $3.5K | $3.5K | ||||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $3.9M | $4.3M | $3.1M | $4.9M | $4.5M | $2.7M | $199.8K | $158.8K | $4.7M | $12.3M | $8.7M | $9.1M | $10.3M | $4.2M | $4.6M | |||||||||||||||||||||||||||
| Accounts Payable And Accrued Liabilities Current | $636.2K | $977.8K | $1.1M | $972.7K | $1.3M | $801.6K | $606.7K | $1.0M | $153.6K | $417.9K | $211.3K | $192.0K | $238.0K | $114.8K | $72.8K | $106.2K | $62.5K | $27.5K | $45.7K | $28.7K | $10.0K | $13.9K | $33.1K | |||||||||||||||||||
| Retained Earnings Accumulated Deficit | -$18.6M | -$17.5M | -$16.3M | -$13.5M | -$12.6M | -$11.7M | -$9.8M | -$9.1M | -$8.1M | -$5.5M | -$4.5M | -$3.9M | -$2.2M | -$8.6M | -$8.1M | -$5.0M | -$4.3M | -$2.9M | -$2.3M | -$2.0M | -$1.8M | -$1.2M | ||||||||||||||||||||
| Prepaid Expense And Other Assets Current | $225.9K | $113.1K | $152.7K | $246.5K | $120.3K | $133.8K | $79.9K | $121.3K | $204.3K | $581.4K | $99.9K | $206.5K | $220.6K | $167.6K | $230.4K | $311.0K | $525.3K | $29.4K | $23.6K | $39.4K | $40.3K | |||||||||||||||||||||
| Liabilities | $1.4M | $1.7M | $1.9M | $1.8M | $2.1M | $1.6M | $1.5M | $1.9M | $1.6M | $1.2M | $1.2M | $1.2M | $1.2M | $1.2M | $1.3M | $133.7K | $91.7K | $715.5K | $35.2K | $54.2K | $29.3K | $21.3K | ||||||||||||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | -$768.9K | -$856.0K | -$6.7M | -$769.2K | $3.5M | -$102.6K | ||||||||||||||||||||||||||||||||||||
| Liabilities Noncurrent | $667.5K | $685.5K | $703.6K | $739.6K | $757.6K | $775.7K | $811.7K | $829.7K | $847.8K | $883.8K | $901.8K | $919.9K | $955.9K | $973.9K | $946.4K | $11.6K | $11.6K | $15.8K | $15.0K | $15.0K | $15.0K | $0.00 | ||||||||||||||||||||
| Unrealized Gain Loss On Investments | $2.6K | -$3.5K | $390.00 | -$161.8K | $38.8K | $48.5K | $506.2K | -$81.9K | -$346.6K | |||||||||||||||||||||||||||||||||
| Unrealized Gain Loss On Equity Investments | -$35.1K | -$59.5K | -$161.8K | $300.9K | $30.0K | $38.8K | -$117.9K | -$100.8K | $48.5K | $506.2K | -$527.0K | -$81.9K | ||||||||||||||||||||||||||||||
| Bad Debt Recovery Expense | -$20.0K | -$30.0K | -$46.0K | -$7.5K | $85.0K | -$1.0K | -$6.0K | -$1.5K | -$4.0K | |||||||||||||||||||||||||||||||||
| Cash And Cash Equivalents Period Increase Decrease | -$102.6K | -$159.3K | $191.7K | $9.8K | $2.0K | -$11.3K | $8.1K | |||||||||||||||||||||||||||||||||||
| Short Term Investments | $1.9M | $1.9M | $2.3M | $3.2M | $3.1M | $4.1M | $8.6M | $9.8M | $6.0M | |||||||||||||||||||||||||||||||||
| Gain Loss On Investments | -$2.2K | $390.00 | -$104.7K | -$161.8K | $6.7M | -$117.0K | -$427.5K | |||||||||||||||||||||||||||||||||||
| Assets Noncurrent | $220.3K | $279.5K | $295.8K | $304.9K | $309.5K | $229.4K | $229.4K | $229.4K | $382.5K | |||||||||||||||||||||||||||||||||
| Treasury Stock Value Acquired Cost Method | $57.7K | $115.5K | $145.7K | $131.0K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share Based Compensation | $117.0K | $906.8K | $871.6K | $577.7K | $395.1K | $756.0K | $319.6K | $145.0K | $177.5K | $0.00 | ||
| Net Cash Provided By Used In Operating Activities | -$4.7M | -$3.8M | -$3.2M | -$3.5M | -$2.3M | -$1.2M | -$794.3K | $272.6K | -$284.6K | -$181.6K | -$21.5K | -$46.3K |
| Net Cash Provided By Used In Financing Activities | $4.9M | $3.2M | -$471.1K | $4.9M | $3.8M | $2.1M | $382.7K | $19.5K | $2.2M | $20.0K | $575.00 | |
| Increase Decrease In Accounts Payable And Accrued Liabilities | -$993.4K | $633.0K | $339.3K | -$53.7K | $291.1K | $72.5K | $29.2K | -$12.7K | -$14.8K | -$17.8K | $18.0K | $3.5K |
| Net Cash Provided By Used In Investing Activities | $644.0K | $973.8K | -$4.1M | $86.7K | $7.2M | $39.0K | $186.7K | -$250.0K | ||||
| Employee Benefits And Share Based Compensation | $830.3K | $906.8K | $14.1K | $156.0K | $83.7K | $610.5K | ||||||
| Proceeds From Issuance Of Common Stock | $1.7M | $4.9M | $2.1M | $24.5K | $2.0M | $575.00 | ||||||
| Increase Decrease In Prepaid Expense | -$55.3K | $38.9K | $144.7K | |||||||||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $118.5K | $9.1K | -$35.7K | -$55.3K | ||||||||
| Increase Decrease In Deferred Revenue | -$72.1K | -$72.1K | $478.7K | |||||||||
| Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition | $3.4K | $8.6K | $14.1K | $111.0K | ||||||||
| Proceeds From Notes Payable | $18.9K | $20.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q3 2017 | Q1 2013 | Q1 2012 | Q1 2011 | Q3 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share Based Compensation | $178.5K | $169.7K | $168.4K | $173.3K | $379.3K | $169.2K | $162.3K | $96.5K | $100.2K | $127.2K | $54.9K | $54.9K | $112.3K | $37.3K | $649.3K | $30.6K | $87.5K | $86.2K | $30.0K | $30.0K | $40.0K | $45.0K | $45.0K | $0.00 | $0.00 | $0.00 | |||
| Net Cash Provided By Used In Operating Activities | -$1.6M | -$838.2K | -$692.7K | -$789.2K | -$319.3K | -$117.6K | -$149.5K | $191.7K | -$10.2K | -$13.0K | -$11.9K | -$450.00 | |||||||||||||||||
| Net Cash Provided By Used In Financing Activities | -$115.5K | $3.8M | $15.0K | -$9.8K | $20.0K | $15.0K | $575.00 | $8.5K | |||||||||||||||||||||
| Increase Decrease In Accounts Payable And Accrued Liabilities | -$470.7K | $98.1K | $296.1K | -$262.1K | $111.0K | $51.3K | $20.0K | $34.0K | |||||||||||||||||||||
| Net Cash Provided By Used In Investing Activities | $871.4K | $97.6K | -$6.0M | $20.0K | $31.0K | ||||||||||||||||||||||||
| Employee Benefits And Share Based Compensation | $227.1K | $195.3K | $169.7K | $168.4K | $4.2K | $45.0K | $83.7K | ||||||||||||||||||||||
| Proceeds From Issuance Of Common Stock | $20.0K | $0.00 | $575.00 | $8.5K | |||||||||||||||||||||||||
| Increase Decrease In Prepaid Expense | $100.8K | $69.7K | $109.9K | ||||||||||||||||||||||||||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $120.3K | $116.3K | $100.8K | $90.5K | $13.0K | ||||||||||||||||||||||||
| Increase Decrease In Deferred Revenue | -$18.0K | -$18.0K | -$18.0K | $482.8K | |||||||||||||||||||||||||
| Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition | $1.8K | -$1.1K | $8.3K | $11.8K | -$18.1K | $32.3K | $4.2K | $4.2K | $4.2K | $7.6K | $15.1K | $45.0K | |||||||||||||||||
| Proceeds From Notes Payable | $15.0K | $0.00 |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.50 | -$1.19 | -$1.20 | $0.04 | -$0.05 | -$0.04 | -$0.02 | $0.01 | $0.00 | $0.00 | |||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Common Stock Shares Issued | 13.3M | 4.5M | 3.2M | 3.2M | 2.0M | 85.1M | 23.6M | 23.4M | 50.1M | 40.6M | 30.6M | 30.6M | 30.6M |
| Common Stock Shares Outstanding | 13.3M | 4.5M | 2.9M | 3.2M | 2.0M | 85.1M | 23.6M | 23.4M | 50.1M | 40.6M | 30.6M | 30.6M | 30.6M |
| Common Stock Shares Authorized | 100.0M | 100.0M | 100.0M | 100.0M | 500.0M | 500.0M | 500.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M |
| Preferred Stock Shares Authorized | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | ||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||
| Weighted Average Number Of Shares Outstanding Basic | 8.4M | 3.7M | 3.1M | 2.3M | 1.9M | 66.0M | |||||||
| Earnings Per Share Basic | $-0.50 | $-1.19 | $-1.20 | $0.04 | $-0.05 | $-0.02 | $0.01 | ||||||
| Weighted Average Number Of Diluted Shares Outstanding | 8.4M | 3.7M | 3.1M | 2.3M | 1.9M | 66.0M | 49.1M | 52.1M | |||||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 66.0M | 23.5M | 49.1M | 30.6M | 30.6M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q3 2013 | Q2 2013 | Q1 2013 | Q4 2012 | Q3 2012 | Q2 2012 | Q1 2012 | Q3 2011 | Q2 2011 | Q1 2011 | Q3 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.12 | -$0.19 | -$0.23 | -$0.22 | -$0.31 | -$0.28 | -$0.21 | -$0.32 | -$0.29 | $0.00 | $0.06 | $0.00 | $0.00 | -$0.01 | -$0.04 | -$0.01 | -$0.01 | -$0.01 | -$0.01 | $0.00 | -$0.01 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||
| Common Stock Shares Issued | 10.5M | 8.7M | 4.5M | 4.5M | 4.1M | 3.2M | 3.1M | 3.1M | 3.2M | 3.1M | 99.4M | 99.4M | 98.6M | 98.6M | 85.1M | 85.1M | 83.1M | 23.6M | 23.5M | 23.5M | 23.4M | 36.2M | 30.7M | 30.7M | 30.6M | 30.6M | 30.6M | 30.6M | 30.6M | ||||||
| Common Stock Shares Outstanding | 10.5M | 8.7M | 4.5M | 4.5M | 3.7M | 2.8M | 3.1M | 3.1M | 3.2M | 3.1M | 99.4M | 99.4M | 98.6M | 98.6M | 85.1M | 85.1M | 83.1M | 23.6M | 23.5M | 23.5M | 23.4M | 50.1M | 36.2M | 30.7M | 30.7M | 30.6M | 30.6M | 30.6M | 30.6M | 30.6M | |||||
| Common Stock Shares Authorized | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | |||||
| Preferred Stock Shares Authorized | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | |||||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||
| Weighted Average Number Of Shares Outstanding Basic | 9.3M | 6.3M | 4.5M | 4.3M | 3.1M | 2.9M | 3.1M | 3.2M | 3.2M | 2.0M | 2.0M | 2.0M | 2.0M | 84.4M | |||||||||||||||||||||
| Earnings Per Share Basic | $-0.12 | $-0.19 | $-0.23 | $-0.22 | $-0.31 | $-0.28 | $-0.21 | $-0.32 | $-0.29 | $-0.01 | $-0.01 | $0.06 | $0.00 | $-0.03 | $-0.01 | $-0.01 | $-0.01 | $-0.01 | $0.00 | $-0.01 | $0.00 | ||||||||||||||
| Weighted Average Number Of Diluted Shares Outstanding | 9.3M | 6.3M | 4.5M | 4.3M | 3.1M | 2.9M | 3.1M | 3.2M | 3.2M | 2.0M | 2.0M | 2.0M | 2.0M | 96.9M | 85.1M | 84.4M | 23.5M | 23.4M | 23.4M | 50.1M | 50.1M | 52.1M | |||||||||||||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 96.9M | 85.1M | 84.4M | 35.1M | 23.6M | 23.5M | 23.4M | 23.4M | 30.7M | 30.7M | 30.6M | 30.6M | 30.6M | 30.6M | 30.6M | 30.6M |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Professional Fees | $1.1M | $1.2M | $1.7M | $1.5M | $1.6M | $1.2M | $431.0K | $203.6K | $185.3K | $52.0K | |||
| General Insurance Expense | $89.0K | $125.9K | $108.8K | $30.2K | $26.6K | $35.2K | $35.6K | ||||||
| Additional Paid In Capital | $25.8M | $20.3M | $17.5M | $12.3M | $7.0M | $2.6M | $2.0M | $1.9M | $2.9M | $1.1M | $1.1M | $1.1M | |
| Interest Paid Net | $37.3K | $5.1K | $4.9K | $2.2K | $224.00 | ||||||||
| Realized Investment Gains Losses | $3.9K | -$1.0K | -$104.7K | $138.0K | -$100.8K | -$85.2K | $39.8K | ||||||
| Provision For Doubtful Accounts | -$20.0K | -$148.5K | $196.5K | $35.0K | $62.9K | ||||||||
| Investment Income Interest And Dividend | $193.9K | $333.2K | $398.5K | $72.6K | |||||||||
| Investment Income Net | $11.5K | $12.2K | $4.2K | $20.5K | |||||||||
| Stock Issued During Period Value Issued For Services | $135.1K | $83.7K | $35.0K | $2.0M | |||||||||
| Amortization Of Prepaid Stockbased Expense | $90.1K | $108.0K | $578.9K | ||||||||||
| License Fees | $72.1K | $71.3K | |||||||||||
| Stock Issued During Period Value New Issues | $3.4M | $1.7M | $4.9M | $2.1M | $24.5K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q3 2017 | Q4 2013 | Q3 2013 | Q2 2013 | Q1 2013 | Q3 2012 | Q2 2012 | Q1 2012 | Q3 2011 | Q2 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Professional Fees | $313.2K | $299.6K | $273.8K | $258.9K | $386.5K | $318.4K | $338.2K | $570.3K | $365.3K | $402.2K | $248.2K | $196.2K | $331.4K | $270.9K | $671.6K | $415.4K | $312.3K | $77.9K | $108.5K | $78.1K | $128.1K | $36.0K | $18.5K | $76.2K | $36.9K | ||||||||||
| General Insurance Expense | $21.1K | $21.1K | $21.7K | $25.9K | $22.3K | $24.6K | $30.9K | $30.9K | $33.3K | $29.0K | $29.0K | $21.7K | $13.6K | $4.0K | $8.2K | $8.2K | $8.2K | $8.8K | $8.8K | $8.8K | $8.9K | ||||||||||||||
| Additional Paid In Capital | $23.6M | $22.4M | $20.3M | $20.3M | $19.2M | $17.5M | $17.4M | $17.4M | $17.5M | $17.5M | $17.4M | $12.4M | $12.4M | $12.3M | $12.3M | $12.3M | $7.0M | $6.6M | $2.6M | $2.2M | $2.1M | $2.1M | $2.2M | $1.9M | $1.5M | $1.1M | $1.1M | $1.1M | $1.1M | $1.1M | $1.1M | ||||
| Interest Paid Net | $2.1K | $1.9K | $167.7K | $224.00 | |||||||||||||||||||||||||||||||
| Realized Investment Gains Losses | $989.00 | $2.9K | -$1.3K | $234.00 | -$1.9K | -$2.2K | -$623.2K | $234.3K | -$80.9K | $39.8K | |||||||||||||||||||||||||
| Provision For Doubtful Accounts | -$20.0K | -$7.5K | -$6.0K | -$1.5K | -$4.0K | -$5.0K | |||||||||||||||||||||||||||||
| Investment Income Interest And Dividend | $44.6K | $44.9K | $61.8K | $84.9K | $77.0K | $88.2K | $116.2K | $109.6K | $64.4K | $981.00 | $377.00 | ||||||||||||||||||||||||
| Investment Income Net | $2.8K | $2.9K | $3.0K | $3.1K | $3.0K | $3.0K | $18.00 | $18.00 | $8.00 | $6.5K | |||||||||||||||||||||||||
| Stock Issued During Period Value Issued For Services | $83.7K | $8.8K | $8.8K | $8.8K | |||||||||||||||||||||||||||||||
| Amortization Of Prepaid Stockbased Expense | $33.8K | $101.2K | |||||||||||||||||||||||||||||||||
| License Fees | $18.0K | $18.0K | $18.0K | $18.0K | $18.0K | $18.0K | $17.2K | $294.00 | |||||||||||||||||||||||||||
| Stock Issued During Period Value New Issues | $1.2M | $1.7M | $1.7M | $4.9M | $2.1M |
Most recent annual filing with the SEC: March 27, 2026
Data sourced from SEC EDGAR public filings as of August 5, 2026.